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Abstract The present study evaluates the synthesis
of biocompatible osteoconductive and osteoinductive
nano calcium phosphate (CaP) particles by industri-
ally applied, aerosol-derived flame spray pyrolysis
method for biomedical field. Calcium phosphate
nanoparticles were produced in a range of calcium-
to-phosphorus ratio, (1.20–2.19) in order to analyze
the morphology and crystallinity changes, and to test
the bioactivity of particles. The characterization
results confirmed that nanometer-sized, spherical
calcium phosphate particles were produced. The
average primary particle size was determined as
23 nm by counting more than 500 particles in TEM
pictures. XRD patterns, HRTEM, SAED, and SEM
analyses revealed the amorphous nature of the as-
prepared nano calcium phosphate particles at low Ca/P
ratios. Increases in the specific surface area and
crystallinity were observed with the increasing Ca/P
ratio. TGA–DTA analysis showed that the thermally
stable crystal phases formed after 700 C. Cell culture
studies were conducted with urine-derived stem cells
that possess the characteristics of mesenchymal stem
cells. Synthesized amorphous nanoparticles did not
have cytotoxic effect at 5–50 lg/ml concentration
range. Cells treated with the as-prepared nanoparticles
had higher alkaline phosphatase (ALP) enzyme
activity than control cells, indicating osteogenic
differentiation of cells. A slight decrease in ALP
activity of cells treated with two highest Ca:P ratios at
50 lg/ml concentration was observed at day 7. The
findings suggest that calcium phosphate nanoparticles
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produced in this work have a potential to be used as
biomaterials in biomedical applications.
Keywords Flame spray pyrolysis  Nanoparticles 
Calcium phosphates  USC  Osteogenic
differentiation  Nanobiotechnology  Nanomedicine
Introduction
Every year, the worldwide records of bone disorders
and bone defects due to trauma, illnesses, or poor
physical activities increase steeply. In medical treat-
ment of such disorders, damaged bone tissue is
replaced with metallic implants or filled with support-
ive active materials depending on the scar tissue size.
In both treatment approaches, the critical point is the
presence of active calcium phosphate-derived materi-
als whether on the surface of metal implants or in filler
bone cement. These active materials are chosen and
designed to support osteointegration of the implant.
They are designed to trigger cellular regeneration by
bonding biomaterial to host bone tissue. These
biological phenomena could be achieved only by
mimicking the natural bone microenvironment for
cells. Depending on bone tissue type and location, the
calcium phosphate ceramic content and the properties
of tissue differ. In general, the calcium phosphate
phase of bone consists of 65–70 % of bone tissue
(Sadat-Shojai et al. 2013). In natural bone and similar
calcified tissues, biominerals have two distinct fea-
tures: they are nanostructured, and they have low
crystallinity (Alves Cardoso et al. 2012; Sadat-Shojai
et al. 2013). In biological systems, natural biominerals
are favorable to be nanostructured; thus, they can
disperse through organism by mobility and dis-
solubility kinetics of nanomaterials. As the particle
gets smaller in size, the mobility in body will be
higher. Large surface-to-volume ratio of the nanosized
particles provides high crystal growth potential and
thereby biological mineralization. Since large surface
area increases the surface ionic interaction of calcium
phosphate particles with biological environment, Ca?2
ions react with free ions, and crystal apatite nucleation
is favoured, resulting in higher biomineralization
(Barrère et al. 2006; Dorozhkin 2010; Blokhuis and
Arts 2011; Chen et al. 2012). However, the increasing
concentration of smaller nanoparticles results in large
and immobile aggregates, which limits the exposure
dose for nanoparticles to parts per million for
biomedical and toxicology studies (Stark 2011).
Synthetic calcium phosphates are widely used in
biomedical field as a bone substitute and bone-filling
cements due to their chemical similarity to calcium
phosphates in bone. The requirements for calcium
phosphates to be considered as biomaterials are
biocompatibility, biodegradability, bioactivity, osteo-
conductivity, and osteoinductivity. The biocom-
patibility is a terminology which is used to define the
compatibility of materials with living body both at
systemic and cellular levels. The biodegradability
means the degradation of material in body in time,
which results from enzymatic cleavage, or ambient
conditions like pH changes, temperature changes, etc.
Bioactive materials are materials that form an organic
bond with the host tissue. Calcium phosphate particles
are osteoconductive and osteoinductive materials
(Cho et al. 2010; Lobo and Livingston Arinzeh
2010). Osteoconductivity and osteoinductivity are
considered as an indicator of bioactivity. Osteocon-
ductivity is used to define the ability of material in
providing a structure to which cells can adhere,
proliferate, and further propagate for bone tissue
formation. Osteoinductivity defines the potential of
materials for triggering osteogenic differentiation
(Blokhuis and Arts 2011; Salinas et al. 2013). In this
study, calcium phosphate particles were evaluated for
their biocompatibility and bioactivity properties.
Calcium phosphates are synthesized using various
methods that are classified as high-temperature pro-
cess, wet- and dry-based methods (Loher et al. 2005;
Teoh et al. 2010; Sadat-Shojai et al. 2013). Wet-based
methods are chemical precipitation, sol–gel method,
and hydrolysis method. Dry-based methods are solid-
state method and mechano–chemical synthesis.
Among these three methods, wet-based chemical
precipitation is widely preferred, since it is easy to
apply and incurs low cost. In this synthesis method,
precursors are dissolved in aqueous medium at low
temperatures. Organic solvent is not used; therefore,
the method is cost effective and environmentally
friendly (Mohn et al. 2011). The precursors react at
ambient temperature and pressure by controlling pH of
the mixture continuously. Wet-based synthesis
method is stated as an advantageous method to control
the morphology and the mean size of the produced
calcium phosphate powders by tuning the parameters
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externally (Sadat-Shojai et al. 2013). However, the
low temperature affects the reaction efficiency and
leads to impurity of different phases of calcium
phosphates. Meanwhile, the reaction results with low
crystalline particles (Cho et al. 2009). Dry-based
solid-state synthesis method involves mixing of pre-
cursor’s powder. The precursors are mixed; milled,
and sintered at elevated temperatures, and a thermally
stable product is obtained (Tofighi and Palazzolo
2005). Since the reaction takes place in a dry
environment, ions do not interact in solid as in solvent,
resulting in a lower yield than wet-based methods
(Sadat-Shojai et al. 2013). The particles can be
synthesized in nanosizes by dry methods. When they
are used for biomedical applications, they show
reduced contact with body fluid, hindering resorption
(Zhou and Lee 2011).
Amorphous calcium phosphates (ACPs) are one of
the widely used biomaterials for tissue engineering
applications as ionic cement, coating of prosthesis,
and mineral organic composites to benefit from their
physicochemical behavior (Brunner et al. 2007a; Liu
et al. 2008; Combes and Rey 2010; He et al. 2013).
Reactivity of calcium phosphates (dissolution from
the surface of material and re-precipitation as apatite)
in biological environments or stimulated body fluids is
called bioactivity of these biomaterials. ACPs have
higher solubility in aqueous biological environment
compared to crystalline ones resulting in high ionic
concentration in the vicinity, initiating a recrystalliza-
tion of apatite-like deposits. The physiological pH
induces this crystallization (Somrani et al. 2003;
Combes and Rey 2010). This biomineralization is
initiated by the electrostatic interactions between the
calcium and phosphate ions in the body fluids and the
surface functional groups of the biomaterial. In
amorphous materials, lower reaction energy is re-
quired for such interaction of surface functional
groups and local Ca2? and PO4
3- ions. This ion-
exchange phenomenon of resorbable calcium phos-
phates makes this biomaterial very attractive and
preferable for their use as coating materials on
implants ensuring their cohesion with host with the
newly formed mineralized interface, and in composite
carriers for hard tissue engineering applications
ensuring improvement of the mechanical properties
and the biological response by mimicking the bone
matrix with biomineralization.
During bone metabolism, osteoclasts degrade the
mineralized matrix of the defected site in bone, and
preosteoblasts migrate to this site and bone formation
proceeds. In this dynamic mechanism, free Ca2? and
PO4
3- ions have crucial role in cellular activities. Free
ions trigger the chemotaxis of preosteoblasts to defect
site, diffuse into cells, and induce expressions of
differentiation and proliferation growth factors. How-
ever, the exact mechanism is still unknown (Chai et al.
2012). Higher resorbability of ACP assists natural
process; thus, ACPs are osteoconductive by triggering
chemotaxis and osteoinductive by inducing growth
factor expression (Nagano et al. 1996; Chai et al.
2012). Since osseointegration is required in hard tissue
engineering applications for longevity of implants,
ACPs ensure the bone binding by dissolving rapidly,
diffusing into cells, and reacting with collagen protein
(Combes and Rey 2010; He et al. 2013). In aqueous
environment, by high ionic interaction, ACPs show
apatite-like recrystallization. The physiological pH
induces this crystallization (Somrani et al. 2003;
Combes and Rey 2010). Crystalline calcium phos-
phate biomaterials show higher thermal stability than
natural and amorphous ones. Their dissolution rate is
lower, and osseointegration process occurs in slow
manner. In previous studies, implant surface coatings
were studied with amorphous and highly crystalline
calcium phosphates, and their properties were com-
pared on 16 weeks’ polyethersulfone (PES) plate
implants. The mechanical load capacity and bone
implant binding were found higher in amorphous
calcium phosphate coated implants. It was stated that
the high degradability of ACP facilitated interaction of
implant with surrounding bone tissue. The osseointe-
gration of implant increased the mechanical strength
of implant; meanwhile, highly crystalline hydrox-
yapatite-loaded implants were fragile, and their
bonding was weak (Nagano et al. 1996). Moreover,
amorphous calcium phosphate and polymer-based
composite scaffolds have been developed for bone
tissue engineering applications, and in vitro biomin-
eralization of these matrices have been conducted
(Loher et al. 2006; Hild et al. 2011). The bioactivity
differences of amorphous and crystalline calcium
phosphates were examined. Their osteogenesis com-
parison was conducted with mouse osteoblasts on
titanium implant surfaces. The ACPSs showed better
bioactivity than crystal calcium phosphates (Brunner
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et al. 2007b; He et al. 2013). According to the study,
for the higher surface area, smaller particle-sized
amorphous materials showed better osteogenic differ-
entiation on seeded cells (Somrani et al. 2003; Brunner
et al. 2007b).
The improvements in nanotechnology have in-
creased the interest in synthesis of bioceramics in
nanosizes. Flame spray pyrolysis (FSP) method is a
highly promising and versatile method, which enables
the desired nanoparticle design and fabrication
(Madler et al. 2002; Teoh et al. 2010). The precursor
selection and reactor system engineering make FSP
system practically feasible to produce particles with
the desired properties. Previously, a variety of ceramic
powders have been made by FSP system (Pratsinis
1998). The system has been also studied for synthe-
sizing calcium phosphate bioceramics for biomedical
applications (Loher et al. 2005; Maciejewski et al.
2008; Cho and Kang 2008; Dorozhkin 2010; Boccac-
cini et al. 2010; Zhou and Lee 2011; Hild et al. 2012;
Sadat-Shojai et al. 2013).
The FSP system is scalable on particle formation,
morphology, and size compared with wet and dry-
based synthesis methods. The choice of solvents or
liquid precursors affects the combustion reaction. This
provides direct control on primary particle size and
phase of materials. The local temperature and
residence time of particles in flame determines the
crystallinity and nanoscale feature of materials (Cho
and Kang 2008; Teoh et al. 2010). However, in
conventional methods, to scale the particle size,
milling step is required, and for phase transition,
gradual calcination and sintering processes are re-
quired to be performed (Jillavenkatesa and Condreta
1998; Tofighi and Palazzolo 2005; El Briak-Benab-
deslam et al. 2008; Combes and Rey 2010; Chen et al.
2012). Moreover, FSP system is a time-effective
synthesis method. Conventional systems such as sol–
gel synthesis and precipitation synthesis methods take
nearly 12–15 h to perform, and several other drying
steps and heat-treatment cycles are required
(Jillavenkatesa and Condreta 1998; Fathi et al.
2008). The features of the FSP system provide
advantages over the conventional production methods.
Moreover, the thermal quenching in FSP reactor
system while collecting particles results in thermally
metastable particles (Zhou and Lee 2011). A meta-
stable form of calcium phosphate particle synthesis
may provide an opportunity in biomedical studies. In
the natural biomineralization processes, the bone
minerals attach on collagen fibers and provide a site
for further nucleation. Ion movement and localization
induces osteoblast (bone-forming cells) for regen-
eration (Hench and Polak 2002). In previous studies,
this bone growth-inducing property was mimicked by
coating carriers with amorphous metastable form of
calcium phosphate particles. The histological studies
showed that amorphous form has high resorbability
and bioactivity because of the higher bonding affinity
(Overgaard et al. 1999; Sarkar et al. 2001). In light of
these advantages, in this study, we aimed to synthesize
amorphous calcium phosphate nanoparticles by the
FSP method with calcium acetate hydrate as a Ca
source and propionic acid as the solvent. In addition,
the effects of synthesized nanoparticles on the
viability and osteogenic differentiation of the human
urine-derived stem cells (USC) have been investigated
for the first time.
Materials and methods
Synthesis of CaP particles by FSP
In the FSP system, metal precursor type, its chemical
solubility, solvent type, decomposition temperature of
metal precursors, as well as the flame operating
parameters should all be considered to obtain particles
with the desired properties. Precursor and the solvent
type in this study were selected in light of these critical
points and relevant previous studies. In the literature,
calcium oxide or calcium hydroxide was used as
calcium precursors, tributyl phosphate as phosphate
precursor, and 2-ethylhexanoic acid as the solvent
(Loher et al. 2005; Döbelin et al. 2010; Hild et al.
2011). We used the acetate form of Ca precursor, and
propionic acid as the solvent, which worked well with
the acetate form of Ca precursor and provided high
enough combustion enthalpy to decompose the pre-
cursors, sustain the flame, and to produce nanoparti-
cles in our experimental range of Ca/P precursor ratio.
Metal precursors, which were dissolved in propi-
onic acid solvent, were carried into the premixed
burner by means of a liquid pump and a two-phase
nozzle with a capillary insertion, which was located in
the center of the burner. Precursor solution was then
sprayed into the flame by an oxygen dispersion gas,
and ignited by 25 premixed methane/oxygen flamelets
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creating a stable main flame in which the particles
were formed. Particles produced in the flame were
collected on a vacuum applied glass fiber filter (GF/B)
simultaneously. The burner and the chamber where the
GF/B filter was placed were cooled to prevent
overheating (Fig. 1).
Calcium phosphate was prepared using calcium
acetate hydrate (99. 99 % Sigma-Aldrich) dissolved in
propionic acid (for synthesis C99 %, Merck) at 60 C
for 1 h, and tributyl phosphate precursor in liquid form
(assay C99 %, Sigma-Aldrich) was added after clear
solution was observed (0.4 M precursor solution). A
range of different Ca/P ratios from low to high (1.27,
1.38, 1.61, 1.95, and 2.29) were studied. The liquid
precursors were pumped through nozzle with the aid of a
syringe pump (Watson, 323 S/D) at 7 rpm (2.4 ml/min),
dispersed by oxygen (9 l/min) gas, and ignited with
methane (2 l/min) and oxygen (2 l/min) premixed
gases. The formed nanoparticles were collected on
GF/B glass microfiber filter (1.0 lm, Whatman) above
the flame with the aid of a vacuum pump.
Characterization of CaP particles
X-ray diffraction (XRD), scanning electron microscopy
(SEM), transmission electron microscopy–energy dis-
persive spectrometry (TEM–EDS), selected area elec-
tron diffraction (SAED), and high-resolution
transmission electron microscopy (HRTEM) techniques
were used for structural and morphological
characterizations of the nanoparticles. XRD and SEM
were used to determine the crystal phase and to
investigate the general morphology. XRD analysis were
performed by using Rigaku International Corporation
Model:D/MAX2200/PC X-RAY Tube Cu:9407F8.
Particles were analized using JEOL JSM 6335-F high
resolution scanning electron microscope (HRSEM) at
15 kV. TEM and HRTEM were used for more detailed
analyses—for atomic lattice imaging, nanoparticle size,
crystal structure, and morphology of the particles. TEM
was equipped with energy-dispersive X-ray spec-
troscopy (EDS) to determine the surface elemental
distribution. TEM investigations were performed on
JEOL JEM 2100 HRTEM operating at 200 kV (LaB6
filament) and equipped with an Oxford Instruments
INCA X-Sight 6498 EDS system (30 mm2 ATW2
window, Oxford Inca Suite 4.05 software). Images were
taken by Gatan Model 794 Slow Scan CCD Camera and
also by Gatan Model 833 Orius SC200D CCD Camera.
Elemental analyses for the precursors and the prepared
nanoparticles were performed by inductively coupled
plasma mass spectrometry (ICP-MS, Elmer DRC II
model ICP-MS,). Brunauer-Emmett-Teller specific
surface area (SBET) measurements were used to deter-
mine the surface area of the particles produced using
Micromeritics Gemini 2365 Automated Physisorption
Analyzer. Samples were degassed at 250 C for 2 h
under N2 gas atmosphere prior to the analysis. The mean
particle size was measured by HRTEM. To examine the
crystallization p of the prepared nanoparticles, thermo-
gravimetric analysis and differential thermal analysis
(DTA) (Setaram Labsys) were performed. The tem-
perature was programmed from room temperature to
900 C at a heating rate of 10 C/min.
Cell culture studies
USC were isolated from spontaneously voided healthy
human urine (male, 24 years) after obtaining the consent
of Middle East Technical University Human Subjects
Ethic Committee. The isolation procedure was per-
formed as described in the literature (Zhang et al. 2008;
Bharadwaj et al. 2011; Guan et al. 2014). The cells were
cultivated in keratinocyte serum-free medium (KSFM;
Invitrogen,USA) and embryonic fibroblast medium in a
1:1 ratio, 10 % heat-inactivated fetal bovine serum, 1 %
Pen-Strep antibiotics, and supplemented with 5 ng/ml
EGF and 50 ng/ml bovine pituitary extract. The cells
were then passaged at 1:3 ratios. Immunophenotyping of
Fig. 1 a Schematic presentation of FSP system (Sel et al.
2014), b The burning spray of precursors
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stem cells was done by flow cytometric analysis. CD 73,
CD105, and CD 44 were used as mesenchymal positive
markers and CD 34 and CD 45 as negative markers. For
bioactivity and cytotoxicity studies, nanoparticles were
sterilized at 200 C for 30 min. 3 9 105 urine-derived
cells were seeded per well in 24-well plates in osteogenic
medium. Amorphous CaP nanoparticles in DMEM were
added to each well at different final concentrations of
particles of 5, 10, 25, and 50 lg/ml, respectively
(Buschmann et al. 2012). Urine-derived stem cell culture
in osteogenic medium without nanoparticles served as
control. The cell viability assay was performed by
PrestoBlue assay (Invitrogen, USA) at days 1, 3, 5, and 7
according to the manufacturer’s guidelines. At days 7
and 14, ALP activities of the cells in all groups were
determined. After 21 days of incubation, osteopontin
expression was studied by FACS analysis. Sample size
was n = 4 for all conditions.
Statistical analyses
All data are presented as the mean ± standard
deviation (SD). One-way analysis of variance was
used to determine statistically significant differences
among groups, and pairwise comparisons were also
performed with two-sample t test with unequal
variances. Statistical significance was considered for




The prepared nanoparticle powder collected on the
GF/B filter was white in color and had specific surface
area (SSA) between 40 and 50 m2/g, depending on the
Ca/P ratio (Table 1). The increasing Ca/P ratio caused
a slight increase in the SSA due to the increasing Ca
concentration in the main flame environment, which in
turn provided a larger number of seeds for particle
formation, followed by their agglomeration and sin-
tering before leaving the flame. Elemental analysis of
particles after synthesis agreed well with the Ca/P ratio
in starting precursor solution (Table 1).
Scanning electron microscope was used for elemen-
tal microanalyses with energy-dispersive spectrometry
(EDS) technique. For all samples, Ca, P, and O elements
were detected. No contamination was observed.
All calcium phosphate particles that were studied in
the experimental Ca/P ratio range (1.20, 1.31, 1.54,
1.91, and 2.19) were of nanosizes. The representative
low-magnification SEM and TEM images of a sample
are given in Fig. 2, in which the polydisperse size
distribution of particles can be seen. The particles had
spherical shapes with loosely agglomerated structure.
In FSP process, particle formation takes place from
gas-to-particle and/or droplet-to-particle mechanism.
We occasionally observed these particles in the SEM
images with small magnification, and they are shown
in Fig. 3. Some particles formed from droplets are
circled for visibility in the SEM images below. Inset in
image (e) shows a close-up picture of one of the
particles, while image (f) shows the crust of a particle.
Occasional large primary particle observations in
our SEM and TEM pictures indicates that, the particle
formation in our system follows both gas to particle
and droplet to particle mechanism under the condi-
tions we studied. Majority of the primary particle
diameters were less than 100 nm.
The average primary particle size was determined
as 23 nm by counting more than 500 particles in TEM
pictures, as shown in histogram in Fig. 4. Average
particle diameter was almost the same for all samples,
which was expected, because the flame reactor’s
operating conditions were kept the same in all the
experiments. Smallest particle size was about 10 nm.
TEM images of different calcium phosphate ratio
samples are given in Fig. 5. The particles were
amorphous, which indicates the fast cooling of the
particles after their formation, and leaving the flame
without crystallizing. Yet, fused primary particles
with sintered necks were also observed. In Fig. 5f,
HRTEM–SAED pattern for sample Ca/P: 1.31 is
given, which shows the amorphous nature of the







1.27 1.20 40.88 ± 0.05
1.38 1.31 39.10 ± 0.18
1.61 1.54 39.25 ± 0.06
1.95 1.91 50.21 ± 0.05
2.29 2.19 50.00 ± 0.29
a Instrument’s measurement error
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product. However, as the Ca/P ratio was increased,
crystallinity increased as confirmed by XRD results.
Figure 6 shows a crystalline nanoparticle’s HRTEM
image and the corresponding Fast Fourier transform
(FFT) diffractogram for sample Ca/P:2.19, which had
the highest Ca/P ratio and crystallinity.The d spacing is
measured as 0.28 nm which corresponds to 0.2814 nm
of [2 1 1] hydroxyapatite phase (JCPDS 09-0432;
hexagonal, Space Group: P63/m (176); a=9.418 Ao
and c= 6.884 Ao). A sharp peak is observed at two
theta= 31.77 degree in XRD diagram (Fig. 7), which
also corresponds to [2 1 1] hydroxyapatite phase.
The XRD pattern of the as-prepared calcium
phosphate powders showed broad HA reflections
especially up to the Ca/P ratio of 1.54, indicating the
amorphous nature of the particles (Fig. 7). In all the
powders prepared, sharp peaks corresponding to
crystalline CaO, and broad reflections of amorphous
beta-CPP and alpha-TCP existed.
Thermal behavior of the particles up to the
temperature of 900 C by TG–DTA showed mass
losses at *200, *500, 700 C, and at around 800 C
for Ca/P ratios above 1.54 (Fig. 8). 3–4 % mass losses
at all compositions were thought to be due to
desorption of water in the samples
Isolation and characterization of urine-derived
stem cells (USC)
The USC were isolated from healthy 24-year-old men
donors and cultured in KSFM: EFM (1:1) medium. In
3–5 days of isolation, single cells were adhered to
plate surface (Fig. 9a); then medium was changed
three times a week. The remaining particles from urine
were removed by medium change. Since cells were
grown from single adherent cell, they form cobble-
stone like colonies (Fig. 9b). The confluency was
reached at around 10–12 days after isolation (Fig. 9c).
The cells were passaged at 1:3 ratio after 12 days of
incubation.
The characterization of USCs was studied by
analyzing surface marker expression of cells at
passage 3. The results were in correlation with those
of the literature (Zhang et al. 2008; Bharadwaj et al.
2011). USCs were positive for C73, CD105, and CD44
and negative for CD45 and CD31 (Fig. S1).
In vitro cytotoxicity and bioactivity studies
of calcium phosphate nanoparticles
PrestoBlue staining of living cells was performed to
measure cellular viability of USC exposed to CaP
nanoparticles at predetermined time intervals. Relative
viabilities of all compositions were compared (Fig. 10).
There was no statistically significant difference among
different compositions. For all time periods, percent
viabilities of all groups were around 85 %.
The bioactivity of flame-synthesized particles was
studied by measuring ALP enzyme activity. To test
whether the as-prepared particles have a positive
effect on osteogenic differentiation, biochemical ALP
assay was performed, and the results are given as
specific enzyme activity (nmol/min/mg protein). The
effects of different concentrations (5, 10, 25 and
50 lg/ml) of all compositions of calcium phosphate
particles (1.20–2.19 Ca/P ratio range) on th viability
and the osteogenic differentiation of cells were studied
(Fig. 11). Slight decreases in ALP activity of cells
Fig. 2 Representative low-magnification SEM a (scale 1 micron) b (scale 100 nm), and TEM c (scale 1 micron) images showing loose
agglomerations (Ca/P: 1.20)
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treated with two highest Ca:P ratios at 50 lg/ml
concentration were observed at day 7. There were no
statistically significant differences among concentra-
tions and compositions at two-time points. However,
ALP activities of cells for all groups decreased at day
14 for each group.
Discussion
The advances in nanomaterial synthesis methods have





Fig. 3 SEM images of CaP samples, Ca/P: a 1.20, b 1.31, c 1.54, d 1.91, e 2.19, f close-up picture of a particle surface
Fig. 4 Histogram of nanoparticle size
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various fields. In medical treatments, nanostructured
materials are preferred and used in safe dosage levels
(not to exceed ppm levels). It has been reported that
nanosized particles are preferred for engineered
tissues, since smaller size and larger surface area
result in an increase in protein adsorption, improved
cell adhesion on materials, and gene expression
induction (Brunner et al. 2006; 2007b; Stanley 2014).
Over the last decade, interest in nanoparticles
produced by FSP to be applied in biomedical field
Fig. 5 TEM images of different calcium phosphate ratio samples a 1.20, b 1.31, c 1.54, d 1.91, e 2.19 at 100 nm scalebar, f HRTEM-
selected area electron diffraction (SAED) pattern for sample Ca/P: 1.31 that reveals amorphous phase
J Nanopart Res (2015) 17:95 Page 9 of 14 95
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has increased. In this method, formulation and the
chemistry of precursors, and the choice of solvent have
crucial influences on particle formation. Here, we used
calcium acetate hydrate precursor and propionic acid
solvent in our system to produce calcium phosphate
particles. The prepared particles were of nanosize and
in spherical shape, and showed a polydisperse size
distribution, as observed in Fig. 2 and 3. SEM and
TEM results indicated that the primary particle
formation in our system follows both gas-to-particle
and droplet-to-particle mechanisms under the condi-
tions we studied. In the FSP process, particle-forma-
tion mechanism depends on several parameters. The
most important of these parameters are flame tem-
perature (decided by the heat of combustion of the
solvent and premixed flame operating conditions),
liquid precursor flow rate and concentration (effects
the particle residence time and the degree of sintering),
and dispersion oxygen’s flow rate (effects the liquid
droplets size in the spray) (Teoh et al. 2010; Camen-
zinda et al. 2010; Jossen et al. 2005; Sel et al. 2014).
With high flame temperatures and enough residence
time in the flame, the particle-formation mechanism
follows gas-to-particle path only. Otherwise, droplet-
to-particle formation would also take place, because
precursor liquid droplets do not completely evaporate
within the flame. During the solvent evaporation, a
concentration gradient can occur within the droplet
causing a supersaturation of the precursors on the
droplet surface forming a crust and even hollow
eggshell particles, as shown in Fig. 3.
The SEM and TEM pictures show agglomeration of
the primary particles as well, which is generally the
case for the FSP-produced nanoparticle powders due to
their need to minimize their surface free energy. TEM
images indicated spherical primary particles with
necking and forming chain-like aggregate structures.
This kind of morphology is desired because
Fig. 6 a HRTEM image of sample Ca/P: 2.19 (scale: 10 nm),
b magnified and filtered view of the selected part in image
a (scale: 2 nm) and c corresponding FFT diffractogram
Fig. 7 XRD spectrum of the as-prepare d calcium phosphate
particles (open circle) hydroxyapatite, (open triangle) beta-
CPP, (filled square) alpha TCP, (asterisk) CaO
Fig. 8 TGA-DTA curves of flame synthesized calcium phos-
phate nanoparticles
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interconnective microporosity facilitates cell adhesion
and body fluid circulation, and improves osteoconduc-
tive properties (Loher et al. 2005). When sol-
vent ? precursor mixture is sprayed into the flame
environment, precursors pass through a series of
reactions forming the particle nucleus. This is then
followed by the particle growth through agglomeration
and sintering, depending on the residence time in the
flame (Teoh et al. 2010). The existence of particle
necking indicates that some particles stayed long
enough in the high-temperature regions of the flame to
collide and stick together, and form chain-like
aggregates.
HRTEM images of nanoparticles at low Ca/P ratios
showed no atomic lattice fringes, and corresponding
FFT diffractograms in lower Ca/P ratios were consid-
ered as an evidence for amorphous structures (Fig. 6).
However, relatively higher crystallinity was observed
for the samples with Ca/P ratio larger than 1.54. This
observation was also supported by XRD analysis.
Thermal behavior of synthesized calcium phos-
phate nanoparticles was analyzed by thermogravimet-
ric (TG) and differential thermal analysis (DTA) as
given in Fig. 8. All five calcium phosphate composi-
tions (1.20, 1.31, 1.54, 1.91, and 2.19) showed similar
exothermic peaks and similar amounts of weight
losses, but the last two samples had another phase
change around 800 C. The weight loss up to 200 C is
an indicator of adsorbed water evaporation, and up
to *400 C, it is thought to be due to the lattice water
evaporation (Sun et al. 2010). Decomposition tem-
perature and crystallization onset temperature in TG
analysis differ with respect to synthesis methods of
calcium phosphates. In their study, Loher et al.
decided that the weight loss up to 600 C was due to
water vapor and CO2 loss from their sample (Loher
et al. 2005). From 600 to 1250 C, it was interpreted as
crystallization reaction and phase change. In our work,
observation of phase change at about 800 C for
higher Ca/P ratios in DTA results suggests the
formation of beta-TCP, which is a more stable form
of alpha-TCP (Cho et al. 2009). The onset of phase
transition started at about 500 C according to our
TGA results. After 700 C, there was a plateau-like
gradual decrease on TGA curves suggesting the
crystallization of the particles.
Physical and chemical properties of calcium phos-
phate particles determine the biological activity. The
changes in chemical composition as various calcium















































































Fig. 10 Relative cell viability of USC exposed to different
concentrations of calcium phosphate nanoparticles at different
Ca/P ratios. Cells that were not exposed to nanoparticles were
used as control (n = 5)
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to phosphate molar ratio and changes in structural
properties such as crystallinity, porosity and particle
size result in differences in behaviors of particles (Liu
et al. 2008). In this study, properties of nanoparticles
of calcium phosphates at different Ca/P molar ratios
were studied. Biological characterization of particles
was conducted by cell-viability and ALP-activity
studies. In previous studies, cytotoxic effect of CaO
impurity was observed with a decrease in cell viability
(Liu et al. 2008; Mohn et al. 2011). Nanoparticles with
CaO impurity showed no cytotoxic effect on USC
cells when added to the culture media at different
concentrations in our study (Fig. 10). To examine the
effect of amorphous calcium phosphate nanoparticles
on osteogenic differentiation of the USC, ALP enzyme
activity of cells was determined (Fig. 11). Particles
were tested on monolayer cell culture. There was no
statistically significant difference in each day between
cells with different compositions and concentrations
of nanoparticles, and cells without nano calcium
phosphates. Between two time points, a numerical
difference was found, which correlated with os-
teogenic differentiation progress (Lock and Liu
2011). Among all concentrations studied in the range
of 1.20–2.19 Ca/P ratio, 50 lg/ml dose of calcium
phosphate induction showed relatively higher enzyme
activity level than that of control. Meanwhile, there
was a slight decrease in the enzyme activity with the
increasing calcium-to-phosphate ratio in 50 lg/ml
dose groups. As stated above, the physical properties
of nanoparticles influence the biological properties of
material. Characterization results revealed that parti-
cles with the increasing calcium–to-phosphate ratio
had more agglomeration, and showed more crystalline
behaviors according to XRD patterns, HRTEM im-
ages, and FFT diffractograms. The increasing crys-
tallinity decreases the dissolution rate of calcium
phosphate particles (Chai et al. 2012). Therefore, it is
not surprising to observe a relative decrease in the
osteoinductive effect of calcium phosphates at higher
ratios, which is in agreement with the literature (Yuan
et al. 2010). These results allow us to claim that flame-
synthesized amorphous calcium phosphate nanoparti-
cles are cytocompatible and bioactive materials, and
show their potential to integrate into 3D scaffolds or
injectable bone cements.
Conclusion
In recent years, nanosized ACPs have received
increased attention from the researchers for the
development of bone biomimetic nanocomposites
with different polymers for engineering of bone, due
to their high solubility and surface reactivity in
biological environment, capacity to improve me-
chanical properties, biomineralization, and bone re-
generation in nanocomposite scaffolds. This study
reveals that amorphous nanometer-sized calcium
phosphate particles can be synthesized by the FSP
method in time- and cost-effective manner in our
proposed FSP system. The synthesized particles do not
contain any unstable free ion or radical that could have
resulted from pyrolysis, which can pose a risk for
cytocompatibility. We have shown that the as-pre-
pared nanosized calcium phosphates at different Ca/P
ratios at a 5–50 lg/ml range of doses were not toxic on
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Fig. 11 ALP activity of USC that are exposed to different
concentrations of CaP nanoparticles of different compositions in
osteogenic medium. Cells unexposed to nanoparticles were used
as control (n = 4). ALP activities of USC at day 7 were
statistically higher than that observed at day 14 for all groups
(p \ 0.05)
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differentiation of these cells. The results of the in vitro
cell culture studies and characterization support the
compatibility of the particles synthesizes for biome-
dical applications. For future studies, nano-sized
ACPs will be used for the preparation of nanocom-
posite scaffolds mimicking the bone matrix
biologically and biomechanically, using different
scaffold processing techniques and the development
of functional constructs using the easily obtained USC
for the regeneration of bones.
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